Mucormycosis – resurgence of a deadly opportunist during COVID-19 pandemic: Four case reports

作     者：Shalini Upadhyay Tanisha Bharara Manisha Khandait Ankit Chawdhry Bharat Bhushan Sharma 

作者机构：Department ofMicrobiologySGT UniversityGurugram 122505HaryanaIndia Department of Oral and Maxillofacial SurgerySGT UniversityGurugram 122505HaryanaIndia Department of RadiologySGT UniversityGurugram 122505HaryanaIndia 

出 版 物：《World Journal of Clinical Cases》 (世界临床病例杂志)

年 卷 期：2021年第9卷第36期

页      面：11338-11345页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 100401[医学-流行病与卫生统计学] 10[医学] 

主　　题：Zygomycetes Fungal infection COVID-19 co-infection Diabetes mellitus Case series Case report 

摘      要：BACKGROUND Coronavirus disease 2019(COVID-19)patients who suffer severe infection or comorbidities have an increased risk of developing fungal *** is a possibility that such infections are missed or misdiagnosed,in which case patients may suffer higher morbidity and ***-19 infection,aggressive management strategies and comorbidities like diabetes render patients prone to opportunistic fungal *** is one of the opportunistic fungal infections that may affect treated COVID *** SUMMARY We present a case series of four adult males who were diagnosed with mucormycosis post-COVID-19 *** the patients had diabetes and a history of systemic corticosteroids for treatment of *** mean duration between diagnosis of COVID-19 and development of symptoms of mucor was 15.5±14.5(7–30)*** patients underwent debridement and were started on antifungal *** patient was referred to a higher center for further management,but the others responded well to treatment and showed signs of improvement at the last *** Early diagnosis and management of mucormycosis with appropriate and aggressive antifungals and surgical debridement can improve survival.